Effects of natalizumab on oligoclonal bands in the cerebrospinal fluid of multiple sclerosis patients: A longitudinal study.

MLA

Mancuso, R., et al. “Effects of Natalizumab on Oligoclonal Bands in the Cerebrospinal Fluid of Multiple Sclerosis Patients: A Longitudinal Study.” Multiple Sclerosis Journal, vol. 20, no. 14, Dec. 2014, pp. 1900–03. EBSCOhost, https://doi.org/10.1177/1352458514538111.

APA

Mancuso, R., Franciotta, D., Rovaris, M., Caputo, D., Sala, A., Hernis, A., Agostini, S., Calvo, M., & Clerici, M. (2014). Effects of natalizumab on oligoclonal bands in the cerebrospinal fluid of multiple sclerosis patients: A longitudinal study. Multiple Sclerosis Journal, 20(14), 1900–1903. https://doi.org/10.1177/1352458514538111

Chicago

Mancuso, R, D Franciotta, M Rovaris, D Caputo, A Sala, A Hernis, S Agostini, Mg Calvo, and M Clerici. 2014. “Effects of Natalizumab on Oligoclonal Bands in the Cerebrospinal Fluid of Multiple Sclerosis Patients: A Longitudinal Study.” Multiple Sclerosis Journal 20 (14): 1900–1903. doi:10.1177/1352458514538111.